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                                        ABSTRACT 
Objectives: To study the prevalence of the hypothyroidism disorder among pregnant 
women presenting with pre-eclampsia to the tertiary care hospital in South India. The 
secondary objectives were to assess the maternal and fetal outcomes, the comparison 
between the number of antihypertensive medications required.  
Design: Single centre observational case control study  
Setting: Pregnant women with pre-eclampsia in Obstetric and gynaecology ward, 
labour room, Christian Medical College Vellore, Tamil Nadu 
Participants: 277 women fulfilled eligibility criteria, 215 were assessed, 63 in cases 
arm and 152 in control arm.  
Intervention: Thyroid stimulating hormone for all women and if elevated thyroid 
stimulating hormones then thyroid function test and thyroid antibodies were assessed. 
Follow up: 12 weeks  
Main outcome measures: 29.3 percent women had hypothyroidism among the women 
presented with pre-eclampsia. Both group were similar in terms of maternal and fetal 
outcomes. There was no significant difference being noted in either arm in terms of 
secondary outcomes, though there was increased antihypertensive medication 
requirement noted in group with hypothyroidism. Among women with hypothyroidism 
71.42 percent had subclinical hypothyroidism with 22.2 percent (10 women) being 
thyroid antibodies positive. 
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Conclusion: There is increased prevalence of the hypothyroidism disorder among the 
pregnant women with pre-eclampsia and is a independent risk factor. Routine 
assessment of the women with increased risk should be considered.  
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INTRODUCTION 
Pregnancy is a state with various hormonal changes.  Among these , the disorder which 
goes unnoticed is thyroid hypo-function.  
During pregnancy, thyroid gland undergoes physiological changes. There is moderate 
enlargement of the gland along with increasing vascularisation. There was various 
factors which leads to physiological changes in thyroid gland. The few are being 
mentioned are there is increase in beta human chorionic gonadotropin hormone during 
the first trimester of the pregnancy which stimulates the thyroid gland ,due to structural 
analogy with the  thyroid stimulating hormone. Beta human chorionic gonadotropin has 
thyrotrophic activity which decreased the serum thyroid stimulating hormone levels.  
There is oestrogen stimulation which increases the circulating levels of thyroid binding 
globulin. The proposed mechanism is increased excretion of the iodine secondary to 
fetal intake and placenta metabolism leading to decline in the availability of iodine. 
Total concentrations of thyroxine(T4) and triiodothyronine(T3) increases in first 
trimester of pregnancy achieving the plateau early in second trimester followed by 
reaching concentration 30-100% greater than the pre-pregnancy levels after the rise in 
thyroid binding globulin. 
Thyroglobulin increases during pregnancy secondary to the enhanced activity of the 
thyroid gland. Hypothyroidism in pregnancy complicates pregnancy via various 
mechanisms. It increases the risk of pre-eclampsia. Its has been studies and found that 
the women with hypothyroidism during pregnancy have increased risk of preterm 
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labour and instrumental deliveries. They were found to have increased abortion, 
intrauterine death as compared to women with normal functioning thyroid.  
The studies have also observed that the children born to women with hypothyroidism 
had lower intelligent quotient as compared to children born to women with normal 
functioning thyroid.  
Hence this study was to assess the effects of hypothyroidism presenting with pre-
eclampsia on the maternal and fetal outcomes and also whether hypothyroidism 
precipitates the complications of pre-eclampsia.  
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AIM 
To study the prevalence of thyroid disorder (hypofunction) in pregnant women 
presenting with pre-eclampsia 
OBJECTIVE 
Primary Objective : 
To measure the prevalence  of hypothyroidism in pre-eclampsia  
  
Secondary Objective : 
• To study the contribution of thyroid disorder to the maternal outcomes (mode of 
delivery and adverse outcomes) 
• To assess the time to normalisation of blood pressures pre and post delivery  
• To assess the number of  medications required for the  normalisation of blood 
pressure 
• To study the fetal outcomes(IUGR/ preterm/ still birth)  
  
  
  
  
14 
 
 
 
 
 
 
REVIEW OF LITERATURE  
 
 
 
 
 
 
 
 
15 
 
LITERATURE REVIEW 
During pregnancy thyroid disorder is found to have an increasing prevalence, especially 
of subclinical hypothyroidism which goes undetected in the women. There have been 
studies showing various adverse effects of same during the pregnancy and thereafter. 
Subclinical hypothyroidism is found to be one of the risk factors for  gestational 
hypertension which had not been studied properly so far hence the etiopathogenesis 
have not been clear.. With thyroid disorder being a risk factor for the gestational 
hypertension, the incidence of the pre-eclampsia and worsening of the same was found 
to be high in women with thyroid disorder.  
Pre-eclampsia as already known, is an important cause of maternal and prenatal 
mortality and morbidity in the developing countries. Pre-eclampsia can cause multi-
organ involvement. It is usually characterized by new onset hypertension along with 
proteinuria with or without end organ damage , most often after 20 weeks of gestation 
in a previously normotensive patient. The exact etiopathogenesis for the same has still 
been on debate though there are found to be lots of contributing factors.  
 
EPIDEMIOLOGY OF HYPOTHRYOIDISM IN PREGNANCY: 
GLOBAL: 
A study published in 2017, showed prevalence of hypothyroidism was found to be 
17.1% in first trimester, 14% in second trimester and 5% in third trimester among 
pregnant women in Lebanon. The same study showed increased miscarriages to about 
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2.9 times along with increased pre term delivery with prevalence being 14.6%.There 
was also increased instrumental and caesarean section noted among the group with 
hypothyroidism. i 
A study in United Kingdom showed prevalence of 2.5 percent during pregnancy with 
impaired intelligent quotient noted among children born to women with 
hypothyroidism. ii  
NATIONAL: 
In 2015 a study done in Haryana among pregnant women in their first trimester showed 
the prevalence of hypothyroidism being 21.5 percent had subclinical hypothyroidism. iii  
Other study done in 2014 in North India a tertiary care centre, the prevalence of 
hypothyroidism was found to be 12. This study also demonstrated increased incidence 
of 16.6%of pre-eclampsia in women with hypothyroidism.  
A study done in North India in 2013 to measure the prevalence of the hypothyroidism 
in pregnant women during their first trimester showed the prevalence of 14.3 percent 
and majority of the women had subclinical hypothyroidism. iv 
There was adverse fetal outcomes noted in group with hypothyroidism which included 
spontaneous abortion 16.6%, preterm birth 33.3%, low birth weight 50% , intrauterine 
growth retardation 25% and fetal death 16.6% as compared to the euthyroid patients.v 
There have been various studies which showed increased prevalence of hypothyroidism 
in pregnant women in North India. The studies have shown increased maternal and fetal 
complications secondary to hypothyroidism during pregnancy.vi 
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PATHOPHYSIOLOGY AND ITS EFFECTS : 
HYPOTHYROIDISM IN PREGNANCY: 
Introduction of the hormonal changes in pregnancy: 
Pregnancy is a state where maternal physiology and anatomy undergo profound 
changes. These changes begins just after conception and evolve through the delivery 
following which it revert back completely. The purpose of these changes is to 
accommodate the need of the maternal and foetal unit.  
The maternal endocrine adaptations involve changes in hypothalamus, pituitary, 
parathyroid, thyroid , adrenal glands and ovaries.  
The hypothalamus regulates the endocrine system by coordinating input from multiple 
areas and output via hypothalamic pituitary axis. The axis directly affects the function 
of the thyroid gland, adrenal glands and gonads. This also influences growth, lactation 
and water balance. The hormones stimulated by hypothalamus are gonadotropin 
releasing hormone, corticotrophin releasing hormone, growth hormone releasing 
hormone, thyrotropin releasing hormone and prolactin releasing hormone. The 
circulating concentration of these hormones rise during the pregnancy due to placental 
production of identical or variant hormones.  
Gonadotropin releasing hormones levels increases during the pregnancy. The main 
source is placenta and it plays a role in placental growth and function.  
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Corticotrophin releasing hormone regulates ACTH secretion during the stressful events 
and is expressed by placenta. Its concentration increases in maternal circulation and 
rises throughout the pregnancy.  
Whereas growth hormone releasing hormone concentration stays same throughout the 
pregnancy. 
The pituitary gland enlarges during the pregnancy to threefold because of hyperplasia 
and hypertrophy of lactotrophs which takes six month post partum period to normalise. 
As apposed to hypothalamic responses, gonadotropin concentration across gestation 
decreases which is probably secondary to high estradiol and progesterone concentration 
during pregnancy. Growth hormones production is reduced by 24 weeks of gestation 
and is replaced by rising placental derived growth hormone.  
Pregnancy is a state of hypocortisolism, there is increase in serum adrenocorticotropic 
hormone concentration in response to corticotrophin releasing hormone produced by 
the trophoblast.  As for the posterior pituitary hormones there is fall in antidiuretic 
hormone due to resetting of the osmoreceptors for antidiuretic hormone release and 
thirst.  
The parathyroid hormone levels decline in the first half of the pregnancy , reach a nadir 
in the second trimester and rise thereafter.  
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Thyroid adaptation during the normal pregnancy: 
There is increased in the metabolic needs during a normal pregnancy, hence there are 
changes occur in thyroid physiology. The major changes which are seen during 
pregnancy are vii 
-Increase in serum thyroxine binding globulin(TBG) 
-Stimulation of the thyrotropin(thyroid stimulating hormone) receptor by human 
chorionic gonatropin. 
There are three thyroid hormone binding proteins- thyroxine binding globulin, albumin 
and transthyretin. The Albumin and transthyretin levels remain same throughout the 
pregnancy .The serum thyroxine binding globulin concentration increases two to three 
folds which is thought to be secondary to oestrogen leading to increase in thyroxine 
binding globulin production and sialylation, hence decreasing the clearance of the 
same.viii The other reason thought was, there is increased glomerular filtration rate of 
the mother which increased hepatic secretion and accelerated renal clearance of the 
iodide. The oestrogen cause  prolongation of the half-life thyroid binding globulin from 
15 minutes to 3 days. 
During pregnancy there is increased need for the thyroid hormone to maintain the 
normal levels. To maintain the adequate free thyroid hormone level there is increased 
production of thyroxine and triiodothyronine by the thyroid gland. There is increase in 
both serum total Thyroxine and triiodothyronine levels by 30-100 percent, not the free 
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levels secondary to the thyroxin binding globulin. This plateau by 20 weeks and reaches 
a new steady state leading to pre-pregnancy rate of the overall production rate of thyroid 
hormones. The other cause of the increased metabolism of thyroxine in the second and 
third trimesters is due to a rise in the placental type II and III deiodinases, which 
converts thyroxine to triiodothyronine, which in turn forms a feedback mechanism for 
the increased thyroxine production during the pregnancy. 
Beta human chorionic gonadotropin is a glycoprotein hormones which increases soon 
after fertilization and peak at 10-12 weeks during pregnancy. It had an weak intrinsic 
thyrotrophic activity. At the same time there is increase in thyroxine and 
triiodothyronine levels hence leading to decrease levels of thyroid stimulating 
hormones.ix This leads to transient usually subclinical hypothyroidism in all women 
during the pregnancy. This physiology is seen more in multiple pregnancies and 
hyperemesis gravidarum.  At the pregnancy progresses the human chorionic 
gonadotropin levels normalises with normalisation of the thyroxine and 
triiodothyronine levels hence serum concentration rise slightly to or within the normal 
range.  
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Physiology of the fetal thyroid: 
Foetal thyroid gland develops as an outpouching in the midline of the anterior 
pharyngeal floor. It migrates caudally to reach its final position by 7th week  of gestation. 
The foetal thyroid has the capability of trapping iodine by 12th week of gestation and 
hence can synthesize thyroxine by 14th weeks of gestation. In spite of the synthesizes of 
the thyroxine the significant secretion is usually seen only after 20 weeks of gestation. 
x There is gradual rise in fetal TSH,T4 and TBG to  adult levels by 36 weeks of gestation 
though T3 and free T3 do not rise to the adult levels which is secondary to placental 
type III deiodinase , which converts most fetal T4 to reverse T3. There is an exception 
which is that fetal brain have elevated levels of type II deiodinase.  
Thyroid stimulating hormone transfer across the placenta is not  significant. The T3 and 
T4 transport across the placenta can be considered significant. This is of a very special 
relevance in congenital hypothyroidism. There are studies which have shown umbilical 
cord T4 levels in neonates with congenital hypothyroidism can be up to 50% of the 
normal levels. xi The transferred T4 play a crucial role in near normal fetal cognitive 
development in neonates with congenital hypothyroidism. The trans placental transfer 
or TRH, anti thyroid drugs and thyroid stimulatory immunoglobulin have also been 
noted.  
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Definition : 
Thyroid disorder is common during pregnancy due to various physiological changes. 
The common thyroid disorder seen is hypothyroidism which can be clinical and 
subclinical. A small proportion of women can present with hyperthyroidism.  
Hypothyroidism in pregnancy is defined as elevated serum thyrotropin level in 
combination with a serum free T4 level that is within the pregnancy reference range.xii 
Subclinical hypothyroidism is defined by elevated serum thyroid stimulating hormone 
concentration higher than the upper limit of the pregnancy related reference range 
associated with a normal serum thyroxine.xiii 
Hyperthyroidism is defined as abnormally high levels of thyroid hormones caused by 
an increased synthesis and secretion of thyroid hormones from the thyroid gland.xiv 
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Euthyroidism is defined as normal thyroid physiology. 
 
Effects of hypothyroidism : 
Maternal: 
There are different levels of thyroid stimulating hormones been set for each trimester 
of pregnancy according to the various studies done.  
 First trimester :0.1 to 2.5 
 Second trimester : 0.2 to 3.0 
 Third trimester:0.3 to 3.0 
Most of the time the subclinical hypothyroidism is asymptomatic during the pregnancy 
and may be detected during the screening.  There are multiple studies being published 
over the period of time which has shown adverse effects of the thyroid disorder among 
the pregnant women with improvement in outcome after the initiation of the thyroid 
supplements. 
The most common cause is considered to be autoimmune thyroiditis while other causes 
considered were radioiodine ablation therapy, surgery and rarely central 
hypothyroidism. However the iodine deficiency still remains one of the leading cause 
of hypothyroidism world while both for overt and subclinical hypothyroidism.  
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The frequency of overt and subclinical hypothyroidism have been described in various 
studies and have found different according to the region. Though studies have  
concluded the frequency of subclinical is more as compared to overt hypothyroidism. 
In North America, the hypothyroidism is mainly due to autoimmune aetiology whereas 
in India, it’s a mixed scenario. The untreated hypothyroidism is associated with several 
complications, the most common one being preeclampsia with increased risk of preterm 
labour and low birth weight and also abruption placentae. There is increased risk of 
spontaneous miscarriage and perinatal mortality. 
During pregnancy the symptoms of hypothyroidism such as fatigability, constipation, 
muscle cramps and weight gain are masked, hence making it difficult to make the 
diagnosis of hypothyroidism. The most common adverse effects of hypothyroidism 
seen during pregnancy are: 
 Abortion 
 Anemia 
 Pregnancy induced hypertension and preeclampsia 
 Placental abruption /Post partum haemorrhage  
 Premature birth/Low birth weight /Intra-uterine fetal death /Neonatal respiratory 
distress 
There are various studies which have shown that the presence of hypothyroidism 
subclinical or overt during pregnancy have increased risk of pregnancy induced 
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hypertension.xvThe cause for the pre-eclampsia in hypothyroidism is secondary to the 
placental dysfunction and vascular abnormalities with increased oxidative stress. The 
endothelial cell functions are impaired in patient hence leading to hypertension in 
women. The release of Nitric oxide in patient with hypothyroidism is noted to be altered 
hence leading to endothelial cell dysfunction and vasoconstriction. The prevalence of 
patient with pregnancy induced hypertension and preeclampsia have been found higher 
in women with hypothyroidism. xvi The same studies have shown that the thyroid 
stimulating hormone level was found to be higher in patient with preeclampsia as 
compared to normotensive patients. Along with the thyroid stimulating hormones the 
other laboratory parameter found to be abnormal  were hyperuricemia and low albumin 
levels, worsen in patient with preeclampsia. The hyperuricemia has shown a positive 
correlation with thyroid stimulating hormone levels in women with preeclampsia.  
Apart from pregnancy induced hypertension, hypothyroidism during pregnancy can 
lead to gestational induced diabetes also which is contributed to impaired metabolism 
and insulin resistance. xvii This have been observed that the pregnant women with 
positive thyroperoxidase antibodies positive are more prone for gestational diabetes 
especially during the early trimester. xviii 
The pregnancy losses such as abortion and intrauterine deaths were found to be higher 
in women with hypothyroidism. The studies have shown the pregnancy losses seen in 
women with hypothyroidism was about 5-6 times higher as compared to euthyroid 
women.xix There have been various studies which have shown that the women with 
subclinical hypothyroidism during their first trimester are more prone for the 
miscarriage as compared to later in pregnancy. The premature delivery was found to be 
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higher by around 11-18 percent in women with hypothyroidism. xxThe various studies 
have noticed that the mean gestation age for delivery in pregnant women with 
hypothyroidism was found to bae around 34 weeks which led to increased risk of low 
birth weight, prematurity and placental abruption. This observation was found higher in 
women with subclinical hypothyroidism during the pregnancy.xxi 
The interesting findings noted in various studies is that the presence of both antithyroid 
antibodies in any trimester was associated with preterm premature rupture of the 
membrane.  
There have been various studies demonstrating the adverse effects of hypothyroidism 
both subclinical and overt during pregnancy. The below stated tablets have mentioned 
few studies and the pregnancy outcomes. 
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Apart from the above mentioned adverse event , the percentage of instrumental delivery 
was also found to be higher in pregnant women with hypothyroidism with the highest 
prevalence of need for caesarean section secondary to  either fetal or maternal 
deteriorating condition. xxii 
 
Fetal and neonatal aspects of maternal hypothyroidism : 
Hypothyroidism in mother can lead to various adverse events in the neonates , the most 
commonly seen were low birth weight, preterm delivery and very rarely respiratory 
distress. There have been various studies done to observe the effects of thyroxine in 
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fetal growth and noticed that it  plays an important role in the  normal development of 
the fetal brain.  
The maternal hormone does enter the fetal circulation through the placenta circulation 
which was demonstrated by the presence of specific nuclear receptors and thyroid 
hormone levels at 8 weeks in the coelomic and amniotic fluids. There is fine tune 
maintained regarding the supply of adequate amounts of T3 required for the normal 
fetal brain development with the help of D2 and D3 iodothyronine deiodinases 
interaction during the gestation.  
There have been studies which have shown prevalence of congenital hypothyroidism 
approximately 1 in 4000 new-borns born to the mother with hypothyroidism not treated 
during the pregnancy. About eighty five percentage have thyroid dysgenesis. Others 
aetiologies found were genetic disorder with various mutations. xxiii 
Currently with increased awareness there are more screening programs as implemented. 
A Meta-analysis of seven studies showed significant decrease in IQ by 6.3 points in 
children with congenital hypothyroidism. The severity and duration of the fetal 
hypothyroidism reflect the level of the intellectual impairment.xxiv The new-borns born 
with low T4 levels are found to be more prone for intellectual impairment.  
Derksen-Lubsen and Verkerk have suggested that “ at least part of the brain damage in 
patient with congenital hypothyroidism is caused in utero and cannot be prevented by 
early treatment”.xxv  
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The two changes in management- earlier initiation of treatment and high dose of L-
thyroxine therapy can ameliorate impact of thyroid hormone deficiency on intellectual 
development.   
With above mentioned need to remember that fetal hypothyroidism can be transient. 
The trans placental passage of thyrotropin receptor blocking antibodies occur in only 
women with thyroid autoimmunity. The effect lasting during the neonatal period is 
unclear of the same. The antithyroid drug can also cross the placenta and lead to fetal 
goitre and elevation of the thyroid stimulating hormone in the cord blood. Though there 
are studies for the effect of antithyroid drug during pregnancy and its effect and found 
there was no difference in the intellectual development in children with mother with 
and without therapy. The new born born prematurely also can also have low T4 and T3 
in the first week of their life which normalises subsequently. 
As mentioned above the maternal and fetal adverse events are found more in women 
with hypothyroidism. The common fetal outcome which were observed were low birth 
weight, premature, intrauterine death and among neonates , early death, respiratory 
distress syndrome and later in life intellectual abnormality.  
As already mentioned intrauterine growth patterns are influenced markedly by the 
maternal thyroid function. There are multiple studies which have observed that the 
maternal hypothyroidism have direct correlation with low birth weight in the fetal 
affecting the male infants more than the female infants. This observation was found in 
women with hypothyroidism early in their pregnancy with significant sexual 
dimorphism being observed.xxvi The low birth weight in infants was observed both with 
31 
 
hyper and hypothyroidism. It was found that the hyperthyroidism and hypothyroidism 
individually increases the risk of neonatal low birth weight and appropriate 
management can prevent this complication.xxvii The other postulated theory for the same 
is the incomplete development of hypothalamic pituitary axis in the neonates born to 
mother with hypothyroidism, which can lead to congenital hypothyroidism in neonates. 
xxviii 
Still birth and intrauterine death was found to be higher in mother with hypothyroidism. 
It was found higher in women with overt hypothyroidism as compared to subclinical 
hypothyroidism. The most common cause of the still birth or intrauterine death was 
found to be secondary to fetal hydrops secondary to hypothyroidism in fetus.xxix 
During the early neonatal period, neonate born to mother with subclinical 
hypothyroidism have found to have increased risk of respiratory distress which can be 
contributed by the prematurity and low birth weight as compared to the neonate born to 
euthyroid mother.xxx 
The infants born to mother with hypothyroidism have increased risk of congenital 
hypothyroidism and development and intellectual problems. There have been various 
studies which have demonstrated the same. According to the studies done in various 
part of the world, have demonstrated that the neonates with thyroid deficiency required 
special need for education. The studies have demonstrated that the national minimum 
standard for numeracy score was less in  neonates with thyroid dysfunction and most of 
these neonates were found to have congenital hypothyroidism.xxxi 
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Maternal hypothyroidism and hyperthyroidism both are associated with lower IQ in 
children. The thyroid dysfunction can lead to lowering of the grey matter and cortex 
volume  leading to impaired intellectual ability in the childhood. xxxii The children with 
born to hypothyroid mother were found to have congenital hypothyroidism and these 
children were noted to have mild to  moderate neurodevelopment retardation.  The 
outcome for the neurodevelopment retardation was not found to be affected by the 
diagnosis and treatment of the same.xxxiii,xxxiv.There are multiple studies with the same 
findings of lower neuropsychological scores in children with mother with 
hypothyroidism during pregnancy. One study done to compare the cognitive, fine and 
gross motor skills in children found to have congenital hypothyroidism and it was found 
that children with congenital hypothyroidism have compromised fine motor and 
expressive language skills as compared to the normal children.xxxv 
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Pathophysiology of preeclampsia: 
Pathophysiology: 
Preeclampsia is a disorder  affecting various system of the maternal body, with a genetic 
predisposition occurring after 20 weeks of gestation. It is more common in first 
pregnancy and can affects maternal renal, cerebral, hepatic and clotting functions. The 
fetal affects are secondary to the placental insufficiency arising from abnormal 
placentation which is due to failure of trophoblast invasion leading to placental 
insufficiency.  
There are different mechanism of preeclampsia being studied. Few being mentioned as 
below:  
1.Abnormal placentation and vasculogenesis : 
  During normal pregnancy, cytotrophoblast derived from the foetus invades the 
maternal uterine spiral arteries, replaces the endothelium and differentiates into an 
endothelial like phenotype. This leads to formation of high capacitance low resistance  
vessels from high resistance small diameter vessels, to accommodate adequate delivery 
of maternal blood to the developing uteroplacental unit. In preeclampsia this process of 
conversion is impaired leading to persistence of high resistance vessels leading to 
uteroplacental insufficiency. The exact mechanism for the abnormal placental 
trophoblast invasion is unclear. There are number of factors being implicated in 
placentation including the Notch signalling pathway, the transcription factor stork head 
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box 1(STOX 1), various components of renin angiotensin aldosterone system and 
intracellular serpin proteinase inhibitor -9. xxxvi 
Notch signalling is considered to be a crucial component of the process of fetal 
trophoblast cells invasion and maternal blood vessels remodelling. It is considered to 
play an important role in vasculogenesis by modulating differentiation and function  
during cell-cell contact. These trigger serial proteolytic cleavages of the receptors 
releasing the notch intracellular domain that translocate to the nucleus to bind to 
transcription factors and induces downstream targets.  Absence of the notch signalling 
is associated with reduced spiral artery diameter and reduces the placental perfusion.  
The Another described molecular pathway is STOX1 which is a member of winged 
helix transcription factor family. The expression of the mutation of the STOX1 related 
gene leads to inhibition of the trophoblast invasion leading to placental insufficiency 
and preeclampsia.xxxvii 
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2.Activation and dysfunction of the endothelium : 
The one of the important target factor in developing preeclampsia is maternal vascular 
endothelium. The vascular endothelium have properties such as control of smooth 
muscle tone through release of the vasoconstrictor and vasodilatory substances and 
regulation of the anti-coagulation , anti platelets and fibrinolysis functions which is by 
the release of different soluble factors.  
As a known fact that the exchange of nutrients and waste disposal between the mother 
and foetus occurs via the placenta, this interface in formed during the first trimester of 
the pregnancy. The extra villous trophoblast from placenta invades the maternal decidua 
during which the maternal spiral arteries go through various conversion and form high 
capacitance low resistance arteries. This is impaired in preeclampsia leading to 
decreased blood flow to the placenta.  
36 
 
High refluxes of oxygen is required for the replication and proliferation along with cell 
maturation and embryo development. However increase in the oxygen concentration 
can lead to oxidative stress resulting in impairment in the above mentioned process.  
The placental perfusion abnormalities can lead to activation or repress the endothelial 
cells normal functioning. Due to the defective trophoblast invasion the arterial blood 
flow is impaired and results is ischemia and reperfusion state which creates a hypoxic 
environment favouring oxidative stress and oxidative damage with inflammation. xxxviii 
 
 
3.Factors linking placental ischemia/hypoxia with the microvascular dysfunction: 
Angiogenic factors: 
The circulating anti-angiogenic protein and an endogenous inhibitors of vascular 
endothelial growth factor are released in the circulation  in response to placental 
hypoxia, they  enter the maternal blood stream and causes endothelial dysfunction. 
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These factors such as vascular endothelial growth factor(VEGF) and placental growth 
factor(PGF) play a role in angiogenesis and endothelial cell function and health. When 
they are inhibited it causes impairment of angiogenesis along with impairment in the 
endothelial integrity maintenance. In the kidney, inactivation of free VEGF leading to 
endotheliosis and proteinuria.xxxix 
 
 
 
Immune factors and inflammation: 
Disorder of immunity and inflammation was considered to be factor predisposing pre-
eclampsia and this was the first theory to be studies and proven. The theory suggest that 
the particles ranging from large deported multinuclear fragments to subcellular  
component are shed from the syncytial surface of the human placenta, these particles  
trigger inflammatory response. Its being speculated that the smaller particles are 
harmful and can be responsible for inflammatory response in maternal circulation 
leading to preeclampsia.  
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Maternal immune tolerance mechanisms is also considered to be the one of the factors 
in the physiology for the pre-eclampsia. This involves crucial interactions between 
regulatory CD4 T cells and uterine natural killer cells. If the maternal immune system 
fails it leads to poor implantation and poor placentation leading to the impaired placental 
perfusion and activation of the immune system which further leads to miscarriages.  
The renin angiotensin system are suppressed in in women with preeclampsia, since they  
have novel agonistic autoantibody production to the angiotensin II type I receptor which 
can suppress the chronotropic response.  
Endothelin: 
This was first characterised twenty years ago as a potent  vasoconstrictor. It is derived 
from  preproendothelin which in a 203 long amino acid. It acts on smooth muscle and 
causes vasoconstriction and cellular proliferation. The various studies done have found 
that in women with preeclampsia, there is elevated levels of endothelin leading to 
vasoconstriction and reducing the uteroplacental perfusion. xl  
Nitric oxide: 
Nitric oxide plays an important role in modulating arterial pressure. With the help of 
synthetase enzymes, nitric oxide is synthesized endogenously from proteins L-arginine, 
oxygen and NAPDH. Its production is elevated in pregnancy and play an important role 
in vasodilatation. Its reduced production is controversial in preeclampsia though its  
deficiency is commonly seen in preeclampsia hence leading to impaired dilatation of 
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the vessels. The relative deficiency and its importance has yet to be explored in 
preeclampsia.xli 
Oxidative and endoplasmic reticulum stress: 
Oxidative stress is considered one of the factors affect the placental circulation in 
women with preeclampsia , During oxidative stress several oxidative markers are 
released such as peroxynitrite. The concentration of peroxynitrite is higher in vascular 
endothelium of preeclamptic women along with increased oxidative stress which 
precipitates placental ischemia. xlii 
During preeclampsia there appears to be an excess of endoplasmic reticulum stress in 
placenta which activates number of signalling pathways altering the placental function. 
In women with pre-eclampsia it was noted that there is chronic endoplasmic reticulum 
stress process mainly in low levels especially during the second and third trimesters, 
which leads to the activation of growth restricted phenotype and thus increasing the 
levels of endoplasmic reticulum stress leading to activation of pro-inflammatory 
pathways which contributes to maternal endothelial cell activation. xliii 
Hemeoxygenase: 
During stress there is release of gene heme oxygenase and its catalytic product which 
play role in preeclampsia. There is release of heme oxygenase leads to preeclampsia 
and proteinuria though the effect is very modest.  The heme oxygenase enzymes 
activities can ameliorate hypertension and hence worsen preeclampsia though there are 
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several evidence that supports the concept of heme-oxygenase and its product being 
protective against progression of preeclampsia. xliv 
 
The factors predisposing to preeclampsia: 
There have been various risk factors recognised by ACOG for preeclampsia such as 
maternal age, obesity, gestational hypertension and chronic hypertension, diabetes and 
multiple gestations, Chronic renal disease, previous history of eclampsia , 
thrombophilia, systemic lupus erythematosus, family history of eclampsia.  
Gestational diabetes: 
Women with gestation diabetes are found to be at higher risk of gestational hypertension 
and preeclampsia. The various adipokines are found to be dysregulated in gestational 
diabetes mellitus which impairs both metabolic and vascular function which can 
precipitates preeclampsia. xlv women with preeclampsia themselves are two to three fold 
increased in risk of gestational diabetes mellitus. Hence both are found to be risk factors 
for the other. xlvi 
Obesity : 
Obesity can lead to various metabolic abnormalities predisposing both hypertension and 
gestational diabetes. It have been found that overweight and obesity has higher risk of 
both maternal and fetal complication in the form of preterm, low birth weight and 
instrumental deliveries along with hypertension and diabetes in mothers.xlvii There are 
studies which have shown risk incidence of preeclampsia in mother with obesity 
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without diabetes with increased risk by 6 times in pregnancy complicated with 
diabetes.xlviii 
The normal expected weight gain during pregnancy is 25-30 pounds for a Basal 
metabolic index of 18.5 -24.9 in all the three trimesters combined. For women with 
overweight BMI of 25-29.9 , expected weight gain is considered to be 15-25 pounds 
and for obese with BMI of 30 or greater weight gain expected is 11-20 pounds . 
According to the American college of obstetric and gynaecology there is trimester wise 
required increased body weight and body mass index. Any body mass index exceeding 
the recommended is considered to be metabolic syndrome of pregnancy and high risk. 
Below is the table of the body mass index according to the each trimesters.  
 
 
Preeclampsia  and maternal effects:: 
Preeclampsia as mentioned above affects multiple organ system in the body during the 
pregnancy occurring after 20 weeks of gestation. Its definition and pathophysiology 
have been already mentioned above. 
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American College of Obstetric and Gynaecology have defined criteria for the diagnosis 
of preeclampsia:xlix 
 Mild-moderate 
o BP is 140 to 159 mmHg systolic and/or 90 to 109 mmHg diastolic and proteinuria is 
300 mg/24 hours; or ≥1+ (on 2 random urine samples, collected at least 4 hours apart); 
or protein: creatinine ratio is ≥0.3 mg/dL. 
 
o BP is 140 to 159 mmHg systolic and/or 90 to 109 mmHg diastolic and in the absence 
of proteinuria, any of the following is present: 
 Thrombocytopenia, platelets count <100,000/uL 
 Serum creatinine ≥1.1 mg/L or a doubling of the serum creatinine concentration in the 
absence of other renal disease 
 Impaired liver function, elevated blood concentrations of liver transaminases to twice 
normal concentration. 
 Pulmonary oedema 
 Cerebral or visual disturbances.  
 Severe 
o BP is ≥160 mmHg systolic and/or ≥110 mmHg diastolic (on 2 occasions at least 6 hours 
apart, while the patient is on bed rest) and proteinuria is 300 mg/24 hours; or ≥1+ (on 2 
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random urine samples, collected at least 4 hours apart); or protein: creatinine ratio is 
≥0.3 mg/dL. 
o BP is ≥160 mmHg systolic and/or ≥110 mmHg diastolic (on 2 occasions at least 6 hours 
apart, while the patient is on bed rest) and in the absence of proteinuria, any of the 
following is present: 
 Thrombocytopenia, platelets count <100,000/uL 
 Serum creatinine ≥1.1 mg/L or a doubling of the serum creatinine concentration in the 
absence of other renal disease 
 Impaired liver function, elevated blood concentrations of liver transaminases to twice 
normal concentration 
 Pulmonary oedema 
 Cerebral or visual disturbances.  
 
According to the National Instituted for Health and care Excellence(NICE,UK) lcriteria 
preeclampsia is defined as new onset hypertension (BP>_140mmHG systolic and /or >-
90mmHg diastolic, based on 2 measurement taken at least 4 hours apart)occurring after 
20 weeks of gestation in a pregnant women with proteinuria(urinary excretion of >-
0.3gm protein in 24 hours) 
It has classified preeclampsia based on severity: 
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to 149 mmHg systolic and/ or 90 to 99 mmHg diastolic 
 
 
Australia and New Zealand have different criteria. In India ACOG criteria is being 
followed.  
Preeclampsia can present just as high blood recording with no other clinical symptoms 
and in severe stages can have: 
 Persistent severe headache  
Visual problems(blurred or double vision, blind spots, flashes of light) 
New shortness of breath(secondary to pulmonary oedema) 
Epigastric region pain  
In severe stage the blood pressure will be high (BP>160/110) with renal dysfunction , 
thrombocytopenia, abnormal liver test and pulmonary oedema.  
Apart from above it can also cause preterm labour, abruption placentae and postpartum 
haemorrhage. 
Preeclampsia can proceed to eclampsia causing seizure. It worse case can cause HELLP 
syndrome which is characterised by haemolysis, elevated liver enzymes and low 
platelets.li 
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The process is completely reversed by the delivery of the fetus and placenta, but the 
fetus are usually compromised due to the effects of the same and their survival becomes 
low.  
Fetal: 
In preeclampsia there is placental insufficiency hence decreased oxygen and nutrition 
supply to the fetus. Following abnormality can be seen to observe the effect of 
preeclampsia: 
 Abnormal non stress test or biophysical profile score 
 Slowed growth of the baby, usually noted by the ultrasound examination 
 Decreased amount of amniotic fluid(oligohydramnios)  
 Decreased blood flow through the umbilical cord by Doppler test 
In foetus it can lead to  intrauterine growth restriction, prematurity and preterm labour. 
The main impact of preeclampsia is  intrauterine growth retardation which is secondary 
to uteroplacental insufficiency. There are multiple short and long term effects. Due to 
altered fetal growth it results in fetal liability. Fetal health is greatly compromised, 
leading to fetal morbidity and mortality.  
The long term effects are seen in infants with intrauterine growth retardation, they are 
at higher risk of developing hypertension, coronary artery disease and diabetes in adult 
life.  
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Many foetuses have to adapt to a limited supply of blood and nutrition and hence they 
permanently change their structure and metabolism which later in life can lead to 
coronary artery disease, diabetes and hypertension. lii 
Hypothyroidism can predispose to preeclampsia and preeclampsia can lead to both short 
term and long term effects in mother and fetus.  
 
Thyroid disorder in pre-eclampsia and its effects: 
Thyroid disorder both hypothyroidism and hyperthyroidism are individual risk factor 
for pregnancy induced hypertension and preeclampsia. There are various way through 
which thyroid dysfunction can precipitates  hypertension though its not been studied 
properly. There have been various studies which have demonstrated that 
hypothyroidism leading to preeclampsia or worsen chronic hypertension during 
pregnancy.   
The various theories postulated for the hypertension in women with thyroid disorder 
were  
I. Systemic and renal vascular smooth muscle contraction leading to increased diastolic 
hypertension– increased peripheral vascular resistance and decreased tissue perfusion  
II. Thyroid can affect the  sympathetic nervous system leading to increase plasma levels 
of nor adrenaline ( increased alpha adrenergic receptor and decreased beta adrenergic 
receptor– decreased cardiac beta receptor and increases peripheral vascular resistance) 
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III. Hypothyroidism can cause an increase in total body water with reactive decrease in 
intravascular volumes and hyponatremia – decrease in glomerular filtration rate 
(limiting the delivery to distal diluting segment)  
IV. TSH- decreases anti diuretic hormone  
V. It is associated with proteinuria resulting in excretion of thyroxine and thyroid binding 
globulins. 
VI. TSH can act as a tissue specific angiogenesis in physiological and pathological 
conditions thus increases levels of VEGF.liii  
As mentioned above thyroid disorder in pre-eclampsia have various mechanism and 
adverse events. As mentioned hypothyroidism causes contraction of the systemic and 
placental vascular smooth muscles leading to the increase in the peripheral resistance 
and diastolic hypertension which in turn decreases the tissue perfusion and placental 
insufficiency, this leads to worsening of the underlying pre-eclampsia or precipitates 
pre-eclampsia and causes placental insufficiency. liv  
There have been studies done to show the effects of the thyroid stimulating hormones 
in mother and they have noticed that the higher the levels of the thyroid stimulating 
hormone , the worse the progression to pre-eclampsia and its adverse events.lv The 
studies have shown the women with recurrent pre-eclampsia apart from the traditional 
risk factors they were noticed to have thyroid dysfunction which was untreated, hence 
it can be expressed as thyroid disorder as a risk factor if not treated for the recurrent 
pre-eclampsia. lvi  
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When pre-eclampsia is complicated with hypothyroidism either overt or subclinical it 
was noted that there were increased maternal and foetal adverse events on the form of 
placental abruption, post partum haemorrhage and cardiac dysfunction. The studies 
have shown that the treatment of the thyroid disorder improves the outcome events both 
maternal and foetal. lvii 
As mentioned the thyroid disorder can complicate pregnancy and is a risk factor for pre-
eclampsia hence this study was to observe the complication and adverse event 
secondary to hypothyroidism in women with pre-eclampsia and to show the need for 
the routine screening for the thyroid disorder in women with high risk. 
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Material and methodology: 
 
Participants: 
Patients 18 years or old and less than 35 years presented after 20 weeks of gestation 
with new onset hypertension along with proteinuria. 
a.INCLUSION CRITERIA : 
• All women presented with pre-eclampsia for the first time  
b. EXCLUSION CRITERIA: 
• Presentation before 20 weeks of gestation  
• Age>35years  or < 18 years  
• Known case of gestational hypertension  
• Known case of thyroid disorder  
• Obesity( based on trimester BMI) 
• Diabetes (gestational diabetes and pre-diabetes mellitus) 
• Renal disease 
• Previous history of eclampsia or gestational hypertension 
• Twin gestation   
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• APLA syndrome  
 
Background and rationale: 
There have been increasing prevalence of preeclampsia and its related complications 
and one of the individual risk factor is hypothyroidism which remains as a 
asymptomatic disease during pregnancy due to overlap with pregnancy’s 
hypermetabolic state and hence it goes undiagnosed . There have been studies to show 
that the maternal and fetal complications were found to be higher in women with 
undiagnosed hypothyroidism during the pregnancy. Therefore it is considered that 
screening for thyroid dysfunction and treatment of the same can prevent preeclampsia 
progression and complications. “THYDOR’ study was to assess the prevalence of the 
thyroid disorder in women with pre-eclampsia and its related complications.  
 
OBJECTIVES: 
Primary objective: 
To measure the prevalence  of hypothyroidism in pre-eclampsia  
To measure the prevalence ,all the women presented with pre-eclampsia for the first 
time  
were assessed and if satisfying the inclusion and exclusion criteria, blood was drawn in 
red non heparinized container, which was processed and thyroid stimulating hormone 
was measured and hypothyroidism was identified based on the trimester specific normal 
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range.  If thyroid stimulating hormone was found to be elevated above the trimester 
specific normal range, thyroid function test was done and for women who were found 
to have overt hypothyroidism , thyroid antibodies was done.  
  
Secondary Objective : 
1. To study the contribution of thyroid disorder to the maternal outcomes (mode of 
delivery and adverse outcomes)- 
Each women were assessed for the maternal outcomes in terms of complications 
secondary to the pre-eclampsia and progression to eclampsia. There was observed for 
the type of delivery and indications for the instrumental delivery and fetal outcomes in 
terms of preterm, low birth weight or intrauterine death.  
 
2. To assess the time to normalisation of blood pressures pre and post delivery - 
To assess the time to normalisation of the blood pressure, women were followed every 
alternate days in the ward and after discharge outpatient based follow up was done, each 
visit blood pressure was monitored and assessed for the need of antihypertensive.  
 
3. To assess the number of  medications required for the  normalisation of blood pressure 
-To assess the number of antihypertensive required , each women underwent strict blood 
pressure monitoring during the in hospital stay and during outpatient visit and they were 
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assessed for the need for antihypertensive medications and dose of drugs were 
optimised accordingly. 
 
4. To study the fetal outcomes(IUGR/ preterm/ still birth) – 
At the time of delivery, new born were assessed for complication such as preterm, 
prematurity, low birth weight, still birth and intrauterine death and also for the medical 
termination of pregnancy and indications.  
 
STUDY DESIGN: 
The ‘THYDOR’ study is an observational case control study to measure the prevalence 
of hypothyroidism in women presenting with pre-eclampsia. The intervention was 
measuring trimester specific range thyroid stimulating hormone in the biochemistry 
laboratory using the standard approved technique.  
After obtaining the approval from the review board, all pregnant women with pre-
eclampsia presenting for the first time in the labour room and ward of the obstetric 
department in Christian Medical College Vellore were assessed for the eligibility 
criteria.  
Thyroid stimulating hormone was done for all the women using Siemen’s 
chemiluminescence immunoassay which is a standard method of measuring thyroid 
stimulating hormone in an individual. After assessing the thyroid status for women with 
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trimester specific range, women was were found to have hypothyroidism were assessed 
for the whether its subclinical or overt hypothyroidism by measuring thyroid function 
test. If thyroid function test were found to be low, women were diagnosed with overt 
hypothyroidism and thyroid antibodies were measured. All women were closely 
followed up during their in hospital stay and outpatient visit for the blood pressure and 
need for the antihypertensive. All women were assessed for the complications 
secondary to pre-eclampsia complicated by thyroid disorder and compared with women 
with pre-eclampsia with normal functioning thyroid. The new born born to the mother 
were also assessed for the complications at the time of the birth.  
After obtaining the written informed consent 
i. Following were assessed only at baseline: 
1.Demographic details: 
  The demographic questionnaire contained age, gestational age, expected date of 
delivery and assessment date along with education level, occupation, family history of 
hypertension, diabetes and thyroid disorder, previous significant family history, Pre 
pregnancy weight and height and basal metabolic rate and current weight, current health 
status(systemic complications of the pre-eclampsia and organ dysfunction) 
ii. Following were assessed at baseline and follow up visits: 
Blood pressure were measured at each visit to assess for the need for the 
antihypertensive medications.  
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*Thyroid antibodies are either positive and negative. Elevated are considered 
positive and normal being negative.  
Setting: Hospital based, in CMC obstetric department with collection of sample over 
1 year with follow up 12 weeks post partum. Data collection starting from June 2016 . 
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Setting: Inpatient , Christian Medical College Hospital Vellore, Tamil Nadu  
Locations: Labour room and obstetric ward  
Units: Obstetric unit 3,4 and 5 
Relevant dates: May  2016- July 2017 
Periods of recruitment- All proven cases of pre-eclampsia fulfilling the inclusion 
and exclusion criteria will included  
Follow up: 12 weeks post partum period  
Data collection: Recruitment and blood investigation  
 
Sample size: 
Based on the previous studies, the prevalence of pregnancy induced hypertension and 
pre-eclampsia was found to be 10.9% and 4.8% in women with hypothyroidism .The 
standard deviation considered in group I being 35 and group II being 37.  With 10% 
mean difference and effect size of 0.277778 and one sided alpha error  of 5 with power 
(1-beta) of 80% with desired confidence interval of 95%, the required sample size 
calculated was 102 for cases and 306 for controls (1:4 control) in a case control study.  
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Data sources & Measurement:  
The data was collected from the patient or patient’s relative if the patient was unable to 
furnish the necessary information by direct interview at the time of enrolment using the 
CRF designed for this study  by the principal investigator. Some of the required data 
required was acquired from the clinical workstation used at the institution (Clinical 
Workstation, Version; Christian Medical College; Department of Computerized 
Hospital Information Processing Services) 
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Data analysis and Statistical methods: 
Data entry was done by the principal investigator in Epidata 3.1 form which was 
prepared based on data abstraction sheet and exported to SPSS for analysis.  
Statistical analysis was done by Dr. Visalakshi Jeyaseelan, Department of Biostatistics, 
Christian Medical College, Vellore using IBM SPSS Statistics version edition. 
 
Funding and approval funding source: 
A sum of Rs.50,000 (Rupees fifty thousand only) was obtained from an institutional 
research grant. (Annexure 6) IRB Fund 22 Y 979   was the active account for the study.  
A sum of Rs 1,00,00( Rupees one lakh only) was obtained from Medicine Unit III 
Special fund. 
 
Institutional Research Board approval and Ethical considerations: 
The research proposal was discussed by the Institutional Review Board in 2016 and 
approval was obtained after receiving the suggested modifications [IRB Min No.IRB 
Min no.10047(OBSERVE) dated:04.04.2016]; and approved to be conducted as 
presented following the modifications on – April 2016. 
 
 Ethical approval was obtained prior to the study. 
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RESULTS 
THESIS RESULTS: 
Baseline characteristics 
All the women presented with pre-eclampsia to the tertiary care centre were enrolled in 
the study. After obtaining the written consent , blood was drawn and thyroid stimulating 
hormone was assessed for each patient. Following which they were assigned in 2 group 
– women with hypothyroidism and euthyroid. Their demographic profile, baseline 
comorbidities, previous significant antenatal history and baseline laboratory parameters 
were assessed. The baseline characteristics in both the hypothyroid and euthyroid arm 
were well matched including the demographic profile, baseline laboratory parameters, 
basal metabolic rate, family history and previous significant antenatal history.  
 Hypothyroidism  Euthyroid  
Age 25.8 years 26.8 years 
Gestation age 35.7 weeks 35.4 weeks  
Pre-pregnancy weight  54.36 kg 56.01 kg 
Height  156.05 cm 161.64 cm 
Basal metabolic rate 22.17 m2 22.52 m2 
Systolic blood pressure  153 mm Hg 151 mm Hg 
Diastolic blood family  104 mmHg 103 mmHg 
Creatinine 0.59 0.569 
Platelets 218762.21 235189.14 
SGOT 
SGPT 
22.05 
15.1 
24.51 
17.26 
TSH 5.16 1.83 
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Results:: 
Overview of trial conduct 
A total of 277 women were fulfilling the inclusion criteria from May 2016 to June 2017. 
Of 277 women, 42 refused to give consent for drawing the blood whereas 20 blood 
sample went wrong because of laboratory error. Only 215 women had their blood draw 
tested and followed for complication.  
The mean age of the women enrolled was 26 years , and most of them presented in their 
third trimester with pre-eclampsia. 
Occupation : 
Most of the women enrolled were housewife with very few being working. Below is 
the figure to demonstrate the same: 
 
Education: 
Around 31.8 percentage of women have education up to higher secondary whereas 31.3 
were graduate. Around 26.2 percent have education less then or up to primary school.  
housewife
93.50%
Skilled
2.3
Semi-
skilled
3.7
housewife skilled semi-skilled
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Obstetric history: 
Most of the women were primigravida, around 69.3 percent whereas in 21.9 percent 
women this was their second pregnancy.   
There were women who had previous abortion and still birth though the cause for the 
same was unknown. 17.7 percent had at least one abortion previously whereas around 
2.3 percent of women had still birth, the cause for which was not sure.  
None of the women enrolled have any risk factor contributing to the preeclampsia and 
its outcome. 
There was no difference found in the gestational age at presentation among the 
hypothyroid and euthyroid women. There mean gestational age at presentation was 
found to be 35 weeks. The blood pressure recording at the time of admission was also 
found to be in similar range among women with hypothyroidism and euthyroidism. The 
mean systolic blood pressure was 153 and diastolic blood pressure being 106 mm of 
Primary
Hinger Sec
Graduate
Post Grad.
EDUCATION
26.60%
31.80%
31.30%
10.70%
Primary Hinger Sec Graduate Post Grad.
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mercury.  There was no difference found in the renal function and liver dysfunction in 
between the two groups.  
There were 18 women found to have clinical hypothyroidism whereas 45 women had 
subclinical hypothyroidism. 
Among the hypothyroidism group, 38.1 percent of women have done their graduation 
whereas around 31.7 percent had finished their higher secondary school and about 6.3 
percent had completed their post graduation. Similar pattern was found among women 
with euthyroidism, 28.5 percent being graduate, 31.8 percent being post higher 
secondary school and 12.6 percent having being finished their post graduation.  
Irrespective of the education most of the women were housewives or had left their jobs 
comprising around 90.3 percent and 95.4 percent subsequently in hypothyroidism and 
euthyroidism group. Whereas only 4.8 percent and 1.3 percent were working as skilled 
professionals among the hypothyroidism and euthyroid group and 4.8 percent and 3.3 
percent as semiskilled profession among each group respectively. 
Most of the women presented with preeclampsia were primigravida comprising 77.8 
percent and 65.8 percent respectively. Among women with hypothyroidism, 14.3 
percent of women had previous at least one abortion whereas around 19.1 percent had 
one abortion in the euthyroid group. Women with hypothyroidism were noticed to have 
no still births in previous pregnancy whereas around 3.3 percent in euthyroid group 
were noted to have one still birth.  
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Family history: 
  Only 14.9 percent had family history of hypertension either in the father or mother and 
8.4 percent had diabetes among family members. There was 2.3 percent of women with 
a family history of hypothyroidism.  
70.70%
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97.20%
57%
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2.30%
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Looking at the family risk factors, among the women with hypothyroidism around 15.9 
percent and women with euthyroidism around 14.5 percent had family history of 
hypertension in either of the parents, whereas only 3.2 percent in hypothyroid and 
around 10.5 percent in euthyroid group  had family history of diabetes mellitus. Only 
1.6 percent in hypothyroid and 2.6  percent in euthyroid group had family history of 
hypothyroidism including parents and siblings 
 
Yes: women with hypothyroidism, No: women with normal thyroid function 
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0.00%
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Outcomes: 
The primary outcome was to study the prevalence of hypothyroidism in women with 
pre-eclampsia in a tertiary care centre in  South  India. After testing the blood drawn , 
29.3 percent women presented with pre-eclampsia had hypothyroidism either 
subclinical or overt hypothyroidism. 
 
Yes: Hypothyroidism  No: Normal thyroid function  
Among the women who were found to have hypothyroidism, there were 18 women with 
overt hypothyroidism and 45 women with subclinical hypothyroidism.  
The secondary outcomes were to assess the difference in the antihypertensive 
requirement and time to normalisation of the blood pressure and maternal and fetal 
complications.  
Clinical symptoms: 
Around 1.9 percent had features of complications in the form of papilledema. 28.8 
percent women were noticed to have pedal oedema which can be secondary to 
29.30%
70.70%
Prevalence of 
hypothyroidism
Yes No
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hypoalbuminemia, proteinuria in preeclampsia or pregnancy induced and 13 percent 
had signs of free fluid.  Only 2 patients, 1 in each group (0.9 percent) progressed to have 
eclampsia and had seizures.  
Papilledema was noticed in only 1 woman (1.6 percent) among women with 
hypothyroidism and 3 women (2 percent )  among women with euthyroidism.  
None of the women had signs of cardiac dysfunction or respiratory distress. 
Women were noticed to have fluid overload status in the form of pedal oedema , 30.2 
percent in hypothyroid and 28.3 percent in euthyroid group. Ascites was noticed in 14.3 
percent and 12.5 percent of women in hypothyroid and euthyroid group respectively. 
Among the women with hypothyroidism one woman progressed to eclampsia and had 
seizure and similar number was noticed in women with euthyroid thyroid function 
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Antihypertensive drugs: 
In total around 42.8 percent women required at least 2 drugs for blood pressure control 
and 36.7 required one drug for the same. There were 6 percent women who did not 
require any antihypertensive and with rest, their subsequent blood pressure were within 
normal limits. There were 14 percent of women who needed 3 drugs for control of blood 
pressure and 0.5 percent one patient required 4 drugs for the same.  
 
Women with hypothyroidism with regards to the antihypertensive requirement, only 4.8 
percent did not require antihypertensive as compared to 6.6 percent in euthyroid group. 
Among the women with hypothyroidism, 27 percent required at least 1 
antihypertensive, 57.1 percent required 2 antihypertensive, 9.5 percent required 3 and 
only 1.6 percent required more than 3 antihypertensive for blood pressure control. 
In euthyroid group, 40.8 percent required only one antihypertensive, 36.8 required 2, 
15.8 required 3 antihypertensive and no women required more than 3 antihypertensive 
for blood pressure control. 
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Yes: women with hypothyroidism 
No: Women with euthyroidism  
 
Fetal outcomes: 
Most of the babies born had normal weight of the gestation at delivery time though 
around 34.6 percent had low birth weight and 3.7 percent were still births with 4.7 
percent being intrauterine deaths.  
While comparing the two groups to look at the effects of hypothyroidism, among the 
women with hypothyroidism, 54.8 percent of babies born had normal birth weight, 29.7 
percent had low birth weight at the time of delivery. 6.5 percent were still born and 3.2 
percent were intrauterine deaths. 
Among the women with normal thyroid level, 57.9 percent had normal birth weight of 
the babies, 34.2 percent had low birth weight. 5.3 percent were still born and 5.3 percent 
had intrauterine deaths.  
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There was no difference found between the two group with regards to the fetal outcome 
 
 
Mode of delivery: 
Most of the women were delivered in CMC though 1.4 percent were delivered outside, 
these women took discharge and were delivered in an outside hospital.  
Emergency caesarean section was done in around 44.9 percent of women either due to 
worsening maternal or fetal condition. Though 45.8 percent had normal vaginal delivery 
and 9.3 percent had instrumental delivery.  
The most common indication for the assisted delivery was non reassuring fetal status 
found in among 74.1 percent with 10.3 percent being secondary to deteriorating 
maternal condition and 6 percent of women had abruption placenta.  
In hypothyroid group- 46.8 percent women had undergone emergency caesarean section 
whereas 11.3 percent had instrumental delivery, the rest had normal delivery. 
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In euthyroid group- 44.1 percent women had undergone emergency caesarean section, 
8.6 percent had instrumental deliveries rest had normal deliveries.  
 
 
Yes: Women with hypothyroidism 
No: Women with normal thyroid level 
 
 
 
 
41.90
%
11.30
%
46.80
%
Yes
Normal Instrument Emergent ISCS
47.40
%
8.60%
44.10
%
No
Normal Instrument Emergent ISCS
73 
 
Indication for instrumental delivery: 
In both the group the predominant indication for instrumental or emergency caesarean 
section was non reassuring fetal status, 75.7 and 73.4 percent in each group respectively.  
Deteriorating maternal condition was noted in 13.5 and 8.9 percent in each group where 
as 5.4 percent and 6.3 percent of women had abruption placenta in each group. 
 
Yes: Women with hypothyroidism, No: Women with normal thyroid function  
Gestational age at delivery: 
There was no difference found with respect to the gestational age at delivery in either 
of the group, with preterm delivery seen in around 43.5 and 44.7 percent respectively. 
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Antihypertensives at discharge: 
Around 43.3 percent of women required antihypertensives at the time of discharge and 
56.7 percent had well controlled blood pressuring not requiring antihypertensive at 
discharge.  
Among the women requiring antihypertensives, around 90.4 percent required only one 
antihypertensive with 8.4 percent only requiring 2 and 1.2 percent requiring 3 
antihypertensive at discharge for optimum blood pressure control.  
Comparison between the two groups: around 50.8 percent of women required 
antihypertensive at the time of discharge among women with hypothyroidism as 
compared to 40.1 percent in euthyroid group. 
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Among the women requiring antihypertensive at discharge, 90.8 percent of women in 
hypothyroid group required at least one antihypertensive at the time of discharge and 
90.4 percent in euthyroid group. 6.5 percent required at least 2 and 3.2 percent required 
more than 2 antihypertensive among the women with hypothyroidism as opposed to 9.6 
percent requiring 2 and none requiring more than 2 antihypertensive at discharge in 
women with normal thyroid function. 
The below graph showed the difference between number of antihypertensive among the 
women requiring antihypertensive at discharge  
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Yes: women with hypothyroidism, No : women with normal thyroid function  
Post natal visits: 
Around 70.7 percent women had at least one postnatal visit to hospital for the blood 
pressure check up with around 16.3 percent had visited at least twice and only 3.7 
percent visited the hospital thrice for subsequent blood pressure monitoring. There were 
about 8.8 percent women who did not come for postnatal follow up for blood pressure 
monitoring after discharge.  
There were women who did not come for postnatal visit for the blood pressure 
monitoring which was about 12.7 percent and 7.2 percent in each group hypothyroid 
and euthyroid.  
In hypothyroid group 60.3 percent women came for at least one follow up, 20.6 percent 
came for at least 2 follow up visits and 6.3 percent came for at least 3 follow up visits 
to outpatient department. In euthyroid group 75 percent came for at least one follow up, 
14.5 percent came for 2 follow up visits  and 2.6 percent came for 3 follow up visits to 
outpatient department. 
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Antihypertensive requirement in post natal period: 
Among the 63 women with hypothyroidism, around 9 women required anti 
hypertensives at 2 weeks, 7 required even at 45 days follow up and 3 required at 60 days 
follow up. Of the women requiring antihypertensive, there was only one woman with 
overt hypothyroidism, rest were subclinical hypothyroidism. Only one woman required 
antihypertensives even after 3 months post delivery and she was found to have overt 
hypothyroidism. Among the women with normal thyroid function, at 2 weeks 35 
women required continuation of the antihypertensives, 7 required a follow up at 45 days 
and 2 at follow up visits at 60 days and one required more than 3 months of 
antihypertensive for blood pressure control.  
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Antihypertensive requirement among the two groups: 
With regards to the maternal and fetal outcomes there was no significant difference 
found between the two groups however there was noted difference between the groups 
with regards to the number of antihypertensive requirement for blood pressure control.  
1. During perinatal period: 
At admission prior to delivery , it was noted that women with hypothyroidism required 
more number of anti hypertensives for blood pressure control.  
Among the women with hypothyroidism, there were 57.1 percent who required at least 
two anti hypertensives for blood pressure control as compared to 36.8 percent in women 
with euthyroidism.   
 
 
2. Antihypertensive in immediate post natal period: 
When compared the need of antihypertensive medications at the time of discharge, there 
was no statically difference found between the two groups.  
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3. Antihypertensive during postnatal period: 
Among the women who required anti hypertensives  during the postnatal period during 
the follow up visits, there was no significant difference found among the two groups 
though it was noticed that 3.2 percent only among women with hypothyroidism required 
3 drugs.  
Subgroup analysis: 
There were 45 women who were found to have subclinical hypothyroidism and 18 
women found to have overt hypothyroidism.  
Among the women with subclinical hypothyroidism , there were 10 women with thyroid 
antibodies being positive.  
1. Comparison between subclinical and overt hypothyroidism: 
In terms of maternal outcomes, when compared the symptoms and gestational age at 
presentation, there was no significant difference found. 
Maternal outcomes:  
In terms of mode of delivery, there was no significant difference being noted among the 
two groups. Though instrumental delivery was found to be more among women with 
overt hypothyroidism.  
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When compared the indications for the instrumental deliveries, both group the main 
indication was non reassuring fetal status followed by deteriorating maternal condition 
and it was not statically significant. 
Fetal outcomes : 
With regards to the fetal outcomes, it was noted that still birth was slightly higher in 
number among women with subclinical hypothyroidism. The other significant finding 
noticed was that the intrauterine death was higher in women with overt hypothyroidism.  
There was no significant difference found among the two groups with regards to the 
gestational age at delivery. 
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 Antihypertensive medications: 
When compared the need of antihypertensive medications among the two groups: 
1. At presentation: 
It was noted that there was small number of women who did not require 
antihypertensive in subclinical hypothyroidism group though it was statically not 
significant.  Though other findings was not significant. 
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2. At Discharge:  
The number of women requiring antihypertensives at discharge was similar in both the 
arms and when compared the number of drugs most of the women in both the group 
required only one single antihypertensive medication for blood pressure control. There 
was only one women in overt hypothyroidism group requiring 3 antihypertensive 
medications and only 2 women in subclinical group who required 2 antihypertensives 
at discharge. 
3. Post natal period: 
During the follow up visit, the need of antihypertensive medications was noted to be 
similar in either of the groups expect that one woman in overt hypothyroidism group 
continued to required 3 antihypertensives even after 3 months post natal for blood 
pressure control.  
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2. Comparison between the women with subclinical hypothyroidism with 
thyroid antibodies positive and with antibodies negative: 
Among the women with subclinical hypothyroidism , there was 22 percent(10 women) 
of women who were found to be thyroid antibodies positive.  
When compared the different outcomes among the women with thyroid antibodies 
positive with subclinical hypothyroidism , this was observed: 
The clinical presentation was similar in both to groups.  
Maternal outcomes: 
The maternal outcomes in terms of mode of delivery, it was noted there was no 
statistical difference between the two groups though instrumental deliveries were seen 
more among women with thyroid antibodies negative .  
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Fetal outcomes: 
When Fetal outcomes were compared, it was noticed that intrauterine death and still 
birth were more among women with thyroid antibodies being negative as compared to 
women with subclinical hypothyroidism with thyroid antibodies being positive. There 
was no difference found with regards to the gestational age at the delivery. This 
difference can be due to the very small number of the women in each arm and hence it 
is not statistically significant.  
 
Antihypertensive medications: 
1. Perinatal period: 
When compared the numbers of antihypertensive required majority of the women 
required 2 antihypertensive in thyroid antibody positive group, though none required 
more than 2 antihypertensives . But it was noted that around 14.25 percent women 
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required 3 or more than 3 drugs of blood pressure control during perinatal period in 
thyroid antibody negative arm and there were around 8.5 percent women among thyroid 
antibody negative  who did not require any antihypertensive for blood pressure control.  
 
2. At discharge: 
In both group 50 percent required antihypertensive medications at discharge. Among 
the women with thyroid antibodies positive , it was noted that all the women required 
only 1 antihypertensive , there was none who required more than one, whereas among 
the women with thyroid antibodies negative, there was 5.7 percent women requiring 2 
antihypertensives and 45.71 percent required only 1 antihypertensive at discharge.  
3. Post natal period: 
There was none who required antihypertensive for more than 2 visits and none went on 
to chronic hypertension. The requirement of the antihypertensives was noted to be 
similar in both the arm.   
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DISCUSSION 
PRIMARY OBJECTIVE: 
1. To measure the prevalence  of hypothyroidism  
 A study published in 2017 by Dima et al , showed prevalence of hypothyroidism was 
found to be 17.1% in first trimester, 14% in second trimester and 5% in third trimester 
among pregnant women in Lebanon. lviii 
In 2017 a study published by Divya et al  among pregnant women in their first trimester 
in Trivandrum, showed the prevalence of hypothyroidism being 5.6 percent had 
subclinical hypothyroidism.lix  
Other study done in 2015 in South India a tertiary care centre by Nabhi et al, the 
prevalence of hypothyroidism was found to be 19.41 percent. lx 
According to the ‘THYDOR’ Thyroid disorder in Pregnancy study , we found that the 
prevalence of hypothyroidism was found to be about 29.3 percent in women presenting 
with pre-eclampsia to the department of obstetrics and gynaecology. 
This study showed increased prevalence of the hypothyroidism (subclinical and overt) 
among pregnant women which can be secondary to probably autoimmune thyroiditis.  
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SECONDARY OBJECTIVES : 
 To study the contribution of thyroid disorder to the maternal outcomes :: 
The studies done previously showed that in hypothyroidism complicating pregnancy there was 
increased risk of pre-eclampsia and post partum haemorrhage. lxi  
A study done by Saki et al in a tertiary care centre in America  to assess the adverse 
complications secondary to the untreated hypothyroidism during and noticed that there was 
increased risk of preterm deliveries. lxii It was also noticed that the route of delivery being 
caesarean section was higher in women with hypothyroidism around 16.2 percent.lxiii Whereas 
a FASTER Trial done in 15 centres on United stated by Jane et all observed that 
hypothyroidism or hypothyroxinaemia was not associated with adverse maternal outcomes. lxiv 
A Indian study done by Sahu et al in 2010 observed that hypothyroidism in women during 
pregnancy either overt or subclinical is associated with increased pregnancy induced 
hypertension, intrauterine growth restriction and demise and increased caesarean section in 
mother. lxv Whereas study done by the Vimal et al showed that hypothyroidism was associated 
with increased risk of miscarriages.lxvi  
According to the “THDOR” study , there was no difference found between the two group with 
regards to the maternal outcomes in terms of mode of delivery, complications of pre-eclampsia. 
The route of delivery and gestation age at delivery was found to be similar in either groups. 
The noted complications with regards to pre-eclampsia was also same in percent with no 
statistical difference being found in both the groups. 
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• To assess the time to normalisation of blood pressures pre and post delivery :: 
The time to normalisation of the blood pressure was found to be similar in both group. There 
was no previous study done to assess the time to normalisation of blood pressure in women 
with hypothyroidism. 
• To assess the number of  medications required for the  normalisation of blood 
pressure:: 
With regards to number of medication required though women with hypothyroidism had 
increased number of the number of antihypertensive required but it was statically significant . 
It was noted that during the perinatal period the number of antihypertensive medications 
required was higher in women with hypothyroidism though it was statically significant, 
whereas the need of antihypertensive medications required in the immediate postpartum period 
and during follow up visits were found to be similar in both the group.   
 
• To study the fetal outcomes:: 
There was study done by Saki et all in America,  showed that neonates born to mothers with 
hypothyroidism had increased preterm deliveries and IUGR rates as compared to neonates born 
to mother with normal functioning thyroid. It was found to be 2.18 times increased risk of 
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intrauterine growth retardation in neonates to mother with hypothyroidism as compared to 
normal functioning thyroid. lxvii 
A study done by Ezzedine et all to look for the correlation between hypothyroidism and 
pregnancy outcomes , showed increased miscarriages to about 2.9 times along with increased 
pre term delivery with prevalence being 14.6%.There was also increased instrumental and 
caesarean section noted among the group with hypothyroidism. lxviii 
A study by Lazarus et al in United kingdom, showed prevalence of 2.5 percent during 
pregnancy with impaired intelligent quotient noted among children born to women with 
hypothyroidism. lxix  
In a study done by Ajmani et al, there was adverse fetal outcomes noted in group with 
hypothyroidism which included spontaneous abortion 16.6%, preterm birth 33.3%, low 
birth weight 50% , intrauterine growth retardation 25% and fetal death 16.6% as 
compared to the euthyroid patients.lxx 
There have been various studies which showed increased prevalence of hypothyroidism 
in pregnant women in North India. The studies have shown increased maternal and fetal 
complications secondary to hypothyroidism during pregnancy.lxxi 
Ajmani et al studied in a tertiary care centre in Delhi, the adverse effects of 
hypothyroidism in mother and its effects on fetal outcome and found that the adverse 
fetal outcomes such as spontaneous abortion, preterm deliveries and intrauterine growth 
retardation was higher in new born born to mother with hypothyroidism during 
pregnancy as compared with new born born to mother with normal thyroid function. lxxii 
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Though THYDOR study did not show any difference in terms of fetal outcomes (birth 
weight, intrauterine deaths and still birth and maturity) in either of the group, hence 
hypo functioning of the thyroid in mother, has not shown any significant association in 
terms of fetal adverse outcomes. 
 
 
Subgroup analysis: 
1. Subclinical and overt hypothyroidism:  
Abalovich et al did a study to assess the adverse outcomes secondary to the 
hypothyroidism among pregnant women, and they noticed that the fetal outcomes in 
terms of abortion and preterm delivery was higher in women with subclinical 
hypothyroidism as compared to overt hypothyroidism, which can be secondary to the 
initiation of the treatment in women with overt hypothyroidism.lxxiii 
A study done in Bangladesh by Sharmeen et al noticed that the pregnancy induced 
hypertension, intrauterine death and neonatal complications such as respiratory distress 
were more among the women with overt hypothyroidism when compared with with 
subclinical hypothyroidism. 
When compared the women with subclinical and overt hypothyroidism , it was noted 
that intrauterine death was found to be higher in women with overt hypothyroidism as 
compared to women with subclinical hypothyroidism. There was no other significant 
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difference found among the women with regards to the maternal outcomes and 
antihypertensive requirement.  
2. Thyroid antibody positive and its correlation to maternal and fetal 
outcomes: 
A Meta-analysis done by Sima et al demonstrated that thyroid antibodies positivity 
among women with hypothyroidism was found to be 20 percent and it was not 
associated with feto-maternal complications. There was no difference found among 
women with thyroid antibodies positive and negative with regards to the fetal and 
maternal outcomes and hence its role was found to be controversial.lxxiv 
Our study also found the prevalence of women with subclinical hypothyroidism with 
thyroid antibodies positive being around 22 percent. There was no statically significant 
difference found with regards to the maternal outcomes though it was noted that the 
intrauterine death and still birth were more in women with thyroid antibodies negative. 
When antihypertensives requirement and other outcomes were compared there was no 
significant difference found, similar findings as in the previous studies done. 
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CONCLUSION 
& LIMITATIONS  
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CONCLUSION: 
The prevalence of the hypothyroidism was found to be higher in the women with pre-
eclampsia. Screening for the thyroid disorders in the women might help in reduction in 
the complications and improve maternal and fetal outcomes, though this study did not 
show any significant difference in outcomes among the groups.  
It was noted that the women with hypothyroidism required more antihypertensive 
medications during the perinatal period as compared to the women with normal thyroid 
function, hence hypothyroidism in women during pregnancy has association with 
worsening blood pressure and increase number of antihypertensive requirement. With 
regards to the thyroid antibodies correlation with maternal and fetal outcomes  failed to 
establish significant correlation between thyroid antibody positivity and maternal and 
fetal adverse outcomes.  
There have been studies done showing maternal hypothyroidism leading the adverse 
fetal outcome mainly noticed during their early childhood and affecting the intelligence 
quotient, though this study have not looked for the same , further studies can be done to 
assess the maternal and fetal outcomes over a long duration.  
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LIMITATIONS 
The limitations of the studies were as follow: 
1 .It was done as a univariate analysis hence many women were excluded 
2. Most of the women presenting with pre-eclampsia have multiple risk factors 
precipitating the outcomes both maternal and fetal. Hence only thyroid disorders as an 
individual risk factor , is a drawback though further studies are required to study thyroid 
disorder with other risk factors during pregnancy and its outcome. 
3. Most of the women had only one follow up visit which can be contributed to the fact 
that the waiting time in outpatient department with a new born was long and hence 
women did not come for proper follow up visits.  
4. The numbers were small to study the effects of thyroid disorder and effects of 
subclinical and overt hypothyroidism in pregnancy and also correlation between thyroid 
antibody positivity and its adverse outcomes.  
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                           CHRISTIAN MEDICAL COLLEGE , VELLORE 
                 DEPARTMENT OF GENERAL MEDICINE 
 
                                     INFORMATION  
              THYROID DISORDER IN PRE-ECLAMPSIA( THYDOR STUDY)  
 
Introduction: 
You are invited to participate in a study to assess the incidence of thyroid disorder in 
pre-eclampsia and its maternal and fetal outcome. During the admission in hospital with 
pre-eclampsia thyroid stimulating hormone test along with thyroid function test and if 
found to have hypothyroid they will be tested for thyroid antibodies and treatment will 
be initiated for the same. You will be followed by till 12 weeks after delivery till the 
blood pressure is normalized. The identity of all subjects agreeing to participate in this 
study will remain concealed and no information that would result in your identification 
will be collected.  
Your participation is voluntary: 
Your participation in this study is voluntary. This form provides you with information 
regarding the purpose of this study, how it will be conducted and how it affects you.  
If you decide to participate in this study you will be asked to sign the consent form 
provided to you. You are free to withdraw from the study at any time after signing the 
form without prior explanation, if you wish to do so.  
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You are free to decline from participating in this study if you do not wish to do so and 
do not need to give an explanation for the same. Declining participation in this study 
will not effect your medical care.  
Kindly take the time to read this form carefully. You are free to consult with the family, 
friends or your treating physician prior to making your decision regarding participation 
in this study.  
 
Background: 
Thyroid disorder is common in women and found to be common in pregnancy and goes 
undetected. It has effect both on mother and the growing baby. It can cause 
hypertension, pre-eclampsia  in mother and at the same time can effect the growth of 
the baby. It can lead to chronic hypertension in mother and mental retardation the baby 
born to the mother. This study is to see the incidence of thyroid disorder in women with 
pre-eclampsia , the maternal outcome and if thyroid disorder is associated with chronic 
hypertension.  
 
What is the purpose of the study? 
The purpose of the study is to find the incidence of thyroid disorder in women with pre-
eclampsia and its associated complications and maternal and fetal outcome and check 
for the correlation between thyroid disorder and chronic hypertension. 
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Who can participate in the study? 
All pregnant women coming to obstetric department for the first time to labour room 
and ward with pre-eclampsia from the month of  May 2016 to December 2016 will be 
eligible to participate in this study. The study aim is to find the incidence of thyroid 
disorder in women with pre-eclampsia and its maternal and fetal outcome with long 
term effect of hypothyroidism on women. The patient would require to give written 
consent for the participation in the same. In case the patient is unable to give an 
informed consent her relative should be wiling for the same.  
 
Who should not participate in the study? 
If you / your relative are unable or unwilling to give consent for the participation in this 
study you would not be included in the same.  
If you have thyroid disorder previously and is on thyroid supplement then you would 
not be included in the same.  
If you have history of hypertension during previous pregnancy, diabetes during previous 
pregnancy or in present pregnancy then you would not be included in the same.  
 
What does the study involve? 
This study will take place in Obstetric department in labour room and ward. Women 
with pre-eclampsia presenting for the first time  with no prior history of thyroid disorder 
and in absence of  risk factors known to attribute to gestational hypertension and pre-
eclampsia  will be advised for  blood test for thyroid stimulating hormone levels and 
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thyroid function test. Women will be followed up to 12 weeks after delivery to assess 
for the normalization of the blood pressure. 
   
What do you have to do ? 
At the time of presentation to labour room and ward with pre-eclampsia, you be will 
asked for the blood test for the thyroid stimulating hormone and  thyroid function test. 
In case if you are found to have hypothyroidism you will be tested for thyroid 
autoantibodies for further treatment.  
 
What are the possible harms of taking part in the study? 
This study require blood sampling once . Following the blood sampling you can feel 
light headed and can have injection site burning and pain. In most cases the likely of 
these complications are less though can happen and need to be watched for.  
 
What are the benefits of participating in this study? 
This study may or may not benefit you directly. The investigators hope that information 
gained from this study will be use for the pregnant women in future for the screening 
of thyroid disorder and monitoring for the complications.  
 
Will taking part in this study affect your treatment in any way? 
All the subjects will receive the same medical treatment as they would receive normally 
if they were not participating in the study. 
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What happens if you decide to withdraw from participating in this study? 
Your participation in this study is entirely voluntary and you are free to withdraw 
permission to participate in this study. Doing so will not affect your treatment in this 
hospital in any way. The study doctor may decide to discontinue the study at any time 
or exclude you from the study at anytime if she/he feels that it in your best interest. If 
you choose to enter the study and then withdraw at a later date, the data obtained from 
you may be used for analysis purpose. 
 
What happens if something goes wrong? 
Your rights as a patient remain the same irrespective of the participation in this study 
and will not be affected by signing this consent form. 
 
Remuneration/compensation: 
Participants will not be paid for taking part in this study 
 
Will your personal details be kept confidential? 
The results of this study may be published in a medical journal, however your 
confidentiality will be respected and no information regarding your identity will be 
released without your consent. Your medical records may be reviewed by persons 
associated with study without your additional consent should you agree to take part in 
the study. 
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Who do you contact if you have any questions or concerns during the study? 
If you have any further questions please contact Dr.Prashansa Sadanshiv via email 
Medicine3@cmcvellore.ac.in 
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CLINICAL RESEARCH FORM 
HYPOTHYROIDISM IN PRE-ECLAMPSIA (THYDOR STUDY) 
DEMOGRAPHIC DATA 
 Serial no: 
 Date of entry:  
 Age : 
 Hospital number : 
 Phone number :  
HISTORY 
 Gravida , para , living , abortion :  
 Gestational age at presentation :  
 Expected date of delivery : 
 Education : 
 Occupation : 
 Income annual : 
 Geographic details : 
 Previous Obstetric history : 
 Outcome of previous pregnancies : 
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Pregnancy 
number 
Maternal 
complications 
Outcome Gest 
age at 
delivery 
Mode 
of 
delivery 
Foetal/neonatal 
complications 
1      
2      
3      
 
Prior Medical history(diabetes/hypertension/thyroid disorder are excluded: 
 Other medical history : 
 Medication history: 
 
Personal: 
 Smoking : 
 Alcohol : 
 
Family history : 
 
 
EXAMINATION 
 Pre-pregnancy weight/First trimester pregnancy weight : 
 BMI : 
 Height : 
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 Present Weight : 
 Blood pressure : 
 Respiratory system : 
 CNS system: 
 Cardiac system: 
INVESTIGATIONS 
 GTT : 
 Proteinuria: 
 Creatinine: 
 Platelets: 
 SGOT: 
 SGPT: 
 TSH: 
 T3: 
 T4: 
 Ftc : 
 TPO:  
 Outcome  of this pregnancy with complications : 
Maternal:  
Fetal: 
 
 
ANC/PNC visits/Blood pressure/ medications: 
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Date  Gestational 
age/PND  
Blood 
pressure  
Medications  
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CONSENT FORM:: 
Study Title: hypothyroidism in pre-eclampsia  
Study number: 
Participant’s name: 
Date of birth/ age in years: 
 
I____________________________________________________________________
__________, son/daughter/wife 
of_______________________________________________ 
Declare that I have read the information sheet provided to me regarding this study and 
have clarified any doubts that I had.  
I also understand that my participation in this study is entirely voluntary and that I am 
free to withdraw permission to continue to participate at any time without affecting my 
usual treatment of legal rights  
I also understand that the study staff and institutional ethics committee members will 
not need my permission to look at my health records even if I withdraw from the trial. 
I agree to this access.  
I understand that my identity will not be revealed in any information released to third 
parties or published. 
I voluntarily agree to take part in this study.  
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Name: 
Signature: 
Date: 
 
Name of witness: 
Relation to participant: 
Date: 
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THESIS DATA 
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